EUR/USD
1.18636
-0.063%
Gold
5073.44
-0.213%
Oil
64.727
-0.014%
USD/JPY
153.085
-0.119%
GBP/USD
1.36202
-0.058%
GBP/JPY
208.509
-0.164%
Real-time News
On February 12th, Morgan Stanley released a technical research report predicting that WuXi Biologics (02269.HK) shares will rise in the next 45 days, with a probability of 70% to 80%. The company previously issued a profit warning, and management indicated accelerated growth in fiscal year 2026. This, coupled with a 16% increase in the number of integrated projects in 2025 and strong momentum in research services, all reflect a strong performance in 2026. Furthermore, the momentum in research services will generate IP-related revenue, further enhancing profitability. The company also recently entered into licensing agreements with Vertex and Zai Lab (09688.HK). Based on WuXi Biologics accelerating revenue growth and profit margin expansion, the bank raised its earnings forecasts for 2026 to 2030 by 4% to 10%, increased its target price from HK$45 to HK$50, and maintained its "Buy" rating.Fitch Ratings: Large Japanese financial groups are better able to withstand interest rate shocks than their peers.Jefferies raised its price target for McDonalds (MCD.N) from $360 to $375.Market news: U.S. Commerce Secretary Rutnick will meet with Japanese Minister of Economy, Trade and Industry Ryosuke Akazawa in Washington on Thursday.Hong Kong-listed AI stocks continued to diverge in the afternoon session. Zhipu (02513.HK) surged over 37%, MINIMAX-WP (00100.HK) rose over 17%, and Vobile Group (03738.HK) climbed over 11%. Kingsoft Cloud (03896.HK) and SenseTime (00020.HK) both rose over 6%. Conversely, Cloud Music (09899.HK) fell over 10.5%, Lenovo Group (00992.HK) dropped over 5%, Kingdee International (00268.HK) and Meituan (03690.HK) declined over 4.5%, and Meitu (01357.HK) fell nearly 4%.
